N-myc downstream regulated gene-1 expression correlates with reduced pancreatic cancer growth and increased apoptosis in vitro and in vivo.
暂无分享,去创建一个
D. Candinas | H. Reber | G. Eibl | O. Hines | Jenny L. Park | B. Gloor | D. Stroka | D. Dawson | E. Angst
[1] V. Go,et al. Epigenetic Regulation Affects N-myc Downstream-Regulated Gene 1 Expression Indirectly in Pancreatic Cancer Cells , 2010, Pancreas.
[2] Monica C. Chen,et al. Bioluminescence Imaging of Angiogenesis in a Murine Orthotopic Pancreatic Cancer Model , 2010, Molecular Imaging and Biology.
[3] Guoqiang Chen,et al. NDRG1 contributes to retinoic acid-induced differentiation of leukemic cells. , 2009, Leukemia research.
[4] A. Jemal,et al. Cancer Statistics, 2009 , 2009, CA: a cancer journal for clinicians.
[5] H. Izumi,et al. N-myc downstream regulated gene 1/Cap43 suppresses tumor growth and angiogenesis of pancreatic cancer through attenuation of inhibitor of kappaB kinase beta expression. , 2009, Cancer research.
[6] H. Reber,et al. Improved survival following pancreaticoduodenectomy to treat adenocarcinoma of the pancreas: the influence of operative blood loss. , 2008, Archives of surgery.
[7] Paola Chiarugi,et al. Anoikis: a necessary death program for anchorage-dependent cells. , 2008, Biochemical pharmacology.
[8] T. Thompson,et al. Antiproliferative effects of AVN944, a novel inosine 5‐monophosphate dehydrogenase inhibitor, in prostate cancer cells , 2008, International journal of cancer.
[9] Junying Yuan,et al. Caspases in apoptosis and beyond , 2008, Oncogene.
[10] Mark J. Smyth,et al. The TRAIL apoptotic pathway in cancer onset, progression and therapy , 2008, Nature Reviews Cancer.
[11] D. Saur,et al. Apoptotic pathways in pancreatic ductal adenocarcinoma , 2008, Molecular Cancer.
[12] H. Reber,et al. Mononuclear cell-derived interleukin-1 beta confers chemoresistance in pancreatic cancer cells by upregulation of cyclooxygenase-2. , 2008, Surgery.
[13] S. So,et al. N-Myc down-regulated gene 1 mediates proliferation, invasion, and apoptosis of hepatocellular carcinoma cells. , 2008, Cancer letters.
[14] K. Tchou-Wong,et al. Egr-1 mediates hypoxia-inducible transcription of the NDRG1 gene through an overlapping Egr-1/Sp1 binding site in the promoter. , 2007, Cancer research.
[15] C. Ko,et al. National Failure to Operate on Early Stage Pancreatic Cancer , 2007, Annals of surgery.
[16] Lan Liu,et al. p53-dependent NDRG1 expression induces inhibition of intestinal epithelial cell proliferation but not apoptosis after polyamine depletion. , 2007, American journal of physiology. Cell physiology.
[17] D. V. Von Hoff,et al. Tumor-stroma interactions in pancreatic ductal adenocarcinoma , 2007, Molecular Cancer Therapeutics.
[18] L. Akslen,et al. Role of Angiogenesis in Human Tumor Dormancy: Animal Models of the Angiogenic Switch , 2006, Cell cycle.
[19] R. Weimann,et al. Cellular differentiation determines the expression of the hypoxia-inducible protein NDRG1 in pancreatic cancer , 2006, British Journal of Cancer.
[20] M. Kuwano,et al. Tumor growth suppression in pancreatic cancer by a putative metastasis suppressor gene Cap43/NDRG1/Drg-1 through modulation of angiogenesis. , 2006, Cancer research.
[21] H. Reber,et al. The G691S RET polymorphism increases glial cell line-derived neurotrophic factor-induced pancreatic cancer cell invasion by amplifying mitogen-activated protein kinase signaling. , 2005, Cancer research.
[22] Mina J Bissell,et al. Modeling dynamic reciprocity: engineering three-dimensional culture models of breast architecture, function, and neoplastic transformation. , 2005, Seminars in cancer biology.
[23] B. Sipos,et al. Pancreatic fibrosis associated with age and ductal papillary hyperplasia , 2005, Virchows Archiv.
[24] M. Westfall,et al. NDRG1 Is Necessary for p53-dependent Apoptosis* , 2004, Journal of Biological Chemistry.
[25] Ying Wang,et al. PTEN Up-Regulates the Tumor Metastasis Suppressor Gene Drg-1 in Prostate and Breast Cancer , 2004, Cancer Research.
[26] Robin L. Anderson,et al. Caveolin-1 inhibits breast cancer growth and metastasis , 2004, Oncogene.
[27] I. Ninomiya,et al. Thiazolidinedione, a peroxisome proliferator-activated receptor-gamma ligand, inhibits growth and metastasis of HT-29 human colon cancer cells through differentiation-promoting effects. , 2004, International journal of oncology.
[28] J. Veltman,et al. Genome-wide array-based comparative genomic hybridization reveals multiple amplification targets and novel homozygous deletions in pancreatic carcinoma cell lines. , 2004, Cancer research.
[29] L. Kretzner,et al. The growth-inhibitory Ndrg1 gene is a Myc negative target in human neuroblastomas and other cell types with overexpressed N- or c-myc , 2003, Molecular and Cellular Biochemistry.
[30] S. Pandol,et al. Extracellular matrix proteins protect pancreatic cancer cells from death via mitochondrial and nonmitochondrial pathways. , 2003, Gastroenterology.
[31] H. Buhr,et al. An Orthotopic Nude Mouse Model for Evaluating Pathophysiology and Therapy of Pancreatic Cancer , 2003, Pancreas.
[32] K. Miura,et al. The Drg-1 gene suppresses tumor metastasis in prostate cancer. , 2003, Cancer research.
[33] F. Bosman,et al. Expression of NDRG1, a differentiation-related gene, in human tissues , 2002, Histochemistry and Cell Biology.
[34] B. Wiedenmann,et al. Interferon γ inhibits growth of human pancreatic carcinoma cells via caspase-1 dependent induction of apoptosis , 2001, Gut.
[35] S. Erdmann,et al. Seven genes that are differentially transcribed in colorectal tumor cell lines. , 2000, Cancer letters.
[36] H. Ford,et al. Drg-1 as a differentiation-related, putative metastatic suppressor gene in human colon cancer. , 2000, Cancer research.
[37] L. Lin,et al. Identification of a stress-induced protein during human trophoblast differentiation by differential display analysis. , 1999, Biology of reproduction.
[38] J. Swinnen,et al. The differentiation‐related gene 1, Drg1, is markedly upregulated by androgens in LNCaP prostatic adenocarcinoma cells , 1999, FEBS letters.
[39] T. Commes,et al. Differential expression of the RTP/Drg1/Ndr1 gene product in proliferating and growth arrested cells. , 1999, Biochimica et biophysica acta.
[40] R. Schilsky,et al. An investigational new drug treatment program for patients with gemcitabine , 1999, Cancer.
[41] G. Giaccone,et al. Current chemotherapeutic possibilities in pancreaticobiliary cancer. , 1999, Annals of oncology : official journal of the European Society for Medical Oncology.
[42] S. Aaronson,et al. Inhibition of tumor cell growth by RTP/rit42 and its responsiveness to p53 and DNA damage. , 1998, Cancer research.
[43] W. Dinjens,et al. A novel gene which is up-regulated during colon epithelial cell differentiation and down-regulated in colorectal neoplasms. , 1997, Laboratory investigation; a journal of technical methods and pathology.
[44] S. Basu,et al. Current trends in the diagnosis and treatment of carcinoma of the pancreas. , 1983, American journal of surgery.